Evidence map›Paper›PMID 19794044›Full record

ArticleJournal of clinical microbiology2009

Characteristics of Candida albicans biofilms grown in a synthetic urine medium.

Priya Uppuluri, Hemamalini Dinakaran, Derek P Thomas, Ashok K Chaturvedi, Jose L Lopez-Ribot

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Myricetin Exerts Antibiofilm Effects onJournal of fungi (Basel, Switzerland) · 2025
    Article
  2. Impact of oleuropein onIranian journal of microbiology · 2025
    Article
  3. Article
  4. Again and Again-Survival ofPharmaceutics · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Molecules (Basel, Switzerland) · 2020
    Article
  9. Design and synthesis of new drugs inhibitors of Candida albicans hyphae and biofilm formation by upregulating the expression of TUP1 transcription repressor gene.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Priya UppuluriDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas 78249, USA.
Hemamalini Dinakaran
Derek P Thomas
Ashok K Chaturvedi
Jose L Lopez-Ribot
Texas Center for Infectious Disease · USThe University of Texas at San Antonio · US

Funding

STRUCTURAL VISUALIZATION IN BIOINFORMATICSG12RR013646 · NCRR · UNIVERSITY OF TEXAS SAN ANTONIO · PI WENK, CAROLA · 1998 to 2011
$19.6M
Candida albicans biofilm dispersion as a key step during candidiasisR21AI080930 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2009 to 2010
$397k
Small molecule inhibitors of Candida albicans biofilm formationR21DE017294 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2007 to 2008
$376k
NCRR NIH HHS 5G12 RR013646-10NCRR NIH HHS G12 RR013646NIAID NIH HHS R21 AI080930NIAID NIH HHS R21AI080930NIDCR NIH HHS 5R21DE017294NIDCR NIH HHS R21 DE017294
6 · The paper itself

Abstract

Urinary tract infections (UTIs) are the most common type of nosocomial infection, and Candida albicans is the most frequent organism causing fungal UTIs. Presence of an indwelling urinary catheter represents a significant risk factor for UTIs. Furthermore, these infections are frequently associated with the formation of biofilms on the surface of these catheters. Here, we describe the characterization of C. albicans biofilms formed in vitro using synthetic urine (SU) medium and the frequently used RPMI medium and compare the results. Biofilms of C. albicans strain SC5314 were formed in 96-well microtiter plates and on silicon elastomer pieces using both SU and RPMI media. Biofilm formation was monitored by microscopy and a colorimetric XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction assay. As in biofilms grown in RPMI medium, time course studies revealed that biofilm formation using SU medium occurred after an initial adherence phase, followed by growth, proliferation, and maturation. However, microscopy techniques revealed that the architectural complexity of biofilms formed in SU medium was lower than that observed for those formed using RPMI medium. In particular, the level of filamentation of cells within the biofilms formed in SU medium was diminished compared to those in the biofilms grown in RPMI medium. This observation was also corroborated by expression profiling of five filamentation-associated genes using quantitative real-time reverse transcriptase PCR. Sessile C. albicans cells were resistant to fluconazole and amphotericin B, irrespective of the medium used to form the biofilms. However, caspofungin exhibited potent in vitro activity at therapeutic levels against C. albicans biofilms grown in both SU and RPMI media.

Indexed as

Antifungal AgentsBiofilmsCandida albicansCaspofunginCulture MediaEchinocandinsFungal ProteinsGene Expression ProfilingHumansLipopeptidesMicrobial Sensitivity TestsSilicone ElastomersUrineAntifungal AgentsCaspofunginCulture MediaEchinocandinsFungal ProteinsLipopeptidesSilicone Elastomers

Identifiers

PMID19794044
PMCPMC2786631
OpenAlexW2157650900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.